Johnson & Johnson Market Cap 2006-2019 | JNJ

Johnson & Johnson market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Johnson & Johnson market cap as of March 30, 2020 is $350.66B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $350.661B $82.059B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $279.966B 0.00
Merck (MRK) United States $195.166B 14.83
Novartis AG (NVS) Switzerland $187.698B 15.63
Pfizer (PFE) United States $181.241B 11.07
Novo Nordisk (NVO) Denmark $142.506B 24.46
Eli Lilly (LLY) United States $132.492B 22.92
Bristol-Myers Squibb (BMY) United States $122.786B 11.65
AstraZeneca (AZN) United Kingdom $116.863B 25.16
Sanofi (SNY) France $111.910B 13.30
AbbVie (ABBV) United States $111.105B 8.42
GlaxoSmithKline (GSK) United Kingdom $93.822B 11.90
Bayer (BAYRY) Germany $54.386B 7.84
H Lundbeck (HLUYY) Denmark $5.767B 10.02
Innoviva (INVA) United States $1.178B 8.13